Protagen to Supply Protein Chips for German Neurodegenerative Dx Project | GenomeWeb
Protagen, a Dortmund, Germany-based protein-array firm, has been selected to take part in a German government-funded consortium focused on biomarker discovery that in Protagen’s case will rely on its flagship UNIarray protein chip platform to study Alzheimer’s disease.
 
The consortium, called NeuroAllianz, is led by researchers at the University of Bonn and backed by an initial three-year, €20 million ($27 million) award from the German Federal Ministry of Research and Education, or BMBF.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.